LAWRENCE, Mass., Jan. 13, 2016 /PRNewswire/ -- To coincide with
the sixth anniversary of the 2010 Haiti earthquake, NxStage Medical,
Inc. (Nasdaq: NXTM), a leading manufacturer of
dialysis products, is recognizing the efforts of medical leaders
and support teams in helping to save the lives of people suffering
from acute kidney injury (AKI) after the devastating earthquake in
Haiti. Immediately following the disaster, Brian Remillard, M.D., Section Chief of
Nephrology and Hypertension at Dartmouth-Hitchcock Medical Center
(DHMC) led a coordinated effort to bring the portable NxStage®
System One™ to Haiti to provide
on-site dialysis therapy to injured survivors. With support from
NxStage, Remillard's efforts have included emergency response
following the earthquake, as well as long-term initiatives focused
on improvements in renal care for patients in Haiti.
"I am committed as a doctor to providing care in the United States and in developing countries
for both outpatient and acute inpatient dialysis," said Dr.
Remillard. "The System One is extremely portable, easy to use and
exactly what we needed to treat AKI patients we found in
Haiti."
After the earthquake, Dr. Remillard partnered with Chief of
Medicine Dr. Philip Cleophat at
Partners in Health, a global health organization committed to
improving the health of poor and marginalized people, to bring
medical education and renal care to the hospital. Partners in
Health worked for three years after the earthquake to build a
300-bed, state-of-the-art hospital, Hopital Universitaire de
Mirebalais (HUM) with the goal of providing comprehensive medical
care to residents of central Haiti, including advanced care for renal
disease with the NxStage System One. In March of last year,
NxStage provided System One training and education to nurses from
the hospital.
"What Dr. Remillard and his team have done over the past six
years is an inspiration," said Joseph E. Turk, president of
NxStage. "We are proud to have the System One playing an important
role in treating patients in need in Haiti."
For more information about the System One or acute renal
replacement therapy, please visit www.nxstage.com.
About the NxStage System One
The System One is used to
provide a range of flexible therapy options in hospitals and
dialysis centers. The NxStage System One is also the first and only
truly portable hemodialysis system cleared specifically by
the FDA for home hemodialysis and home nocturnal
hemodialysis. Its simplicity and revolutionary size (just over a
foot tall) are intended to allow convenient use in patients' homes
and give patients the freedom to travel with their therapy. When
combined with the NxStage PureFlow SL Dialysis Preparation System,
patients are able to further simplify, using ordinary tap water to
create dialysis fluid on demand. Unlike conventional hemodialysis
systems, the System One requires no special infrastructure to
operate. Under the guidance of their physician, patients can use
the NxStage System One, with their trained partners, where, how and
when it best meets their needs, including while they are sleeping -
at home or on vacation and at a medically appropriate treatment
frequency. In addition, NxStage's Nx2Me Connected Health
platform collects important NxStage System One and patient
information for flexible viewing, monitoring and reporting
that may improve patient management and simplify alternative site
care. http://www.nxstage.com/.
About NxStage Medical
NxStage Medical
Inc. (Nasdaq: NXTM) is a medical device company, headquartered
in Lawrence, Massachusetts, USA, that develops,
manufactures and markets innovative products for the treatment of
ESRD and acute kidney failure. For more information on NxStage and
its products, please visit the Company's website
at www.nxstage.com.
Forward-Looking Statements
This release contains
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. All statements contained
in this release that are not clearly historical in nature are
forward-looking, and the words "anticipate," "believe," "expect,"
"estimate," "plan," and similar expressions are generally intended
to identify forward-looking statements. Actual results may differ
materially from those indicated by these forward-looking statements
as a result of various important factors including those that are
discussed in NxStage's filings with the Securities and Exchange
Commission, including the Quarterly Report on Form 10-Q for the
quarter September 30, 2015. NxStage is under no obligation to
(and expressly disclaims any such obligation to) update or alter
its forward-looking statements, whether as a result of new
information, future events or otherwise.
Media contact:
Kristen K. Sheppard, Esq.
ksheppard@nxstage.com
Tel: (978) 332-5923
Logo -
http://photos.prnewswire.com/prnh/20150624/225341
Logo -
http://photos.prnewswire.com/prnh/20110503/MM94799LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nxstage-system-one-use-continues-in-haiti-six-years-after-earthquake-300203790.html
SOURCE NxStage Medical, Inc.